Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03333824” into the
search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D6014C00006” into the search box, and click “Find a Study”.
Full Trial Title: A Phase I Open-label Study to Evaluate the Effect of Multiple Doses of
AZD1775 on the Pharmacokinetics of Substrates CYP3A, CYP2C19, CYP1A2 and to
Provide Data on the Effect of AZD1775 on QT Interval in Patients with Advanced Solid
Tumours
National Clinical Trials number: NCT03333824
AstraZeneca Protocol Number: D6014C00006
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions
and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_03_09 12